John J. L. Jacobs
  • Home
  • Nederlands
  • Resume
    • Science
    • Recent Research
    • Cancer immunotherapy
  • COVID-19
    • Herd Immunity Re-Revisted
      • 1 About herd immunity (HIRR).
      • 2 Three failed attempts.(HIRR)
      • 3. Calculate the costs (HIRR).
      • 4. Incomplete immunity (HIRR).
      • 5. What could possibly go wrong? (HIRR)
      • 6. How should we act? (HIRR)
      • 7. In brief. (HIRR)
    • Simple & complex
    • Epidemic Control
      • Epidemic Control Addendum
    • Summary Two years of COVID-19
    • Two years of COVID-19
      • I. Healthcare threat
      • II. Deceptive virus
      • III. Morbid tales
      • IV. Antivirus immunity
      • V. Stop the outbreak
      • VI. Dark and light reflections
      • VII. Looking forward
    • Humanitarian
    • Questions
      • Disease
      • Vaccines
      • Immunity
      • Epidemics
      • Mutation
      • Politics
    • Virus ethics
      • Transparency
      • Strife
      • Beyond Mortality
      • Special immunity
      • Vaccination
      • Prevent contamination
    • Non-sterilizing immunity
    • Immune responses and vaccines
      • Calculation of infection fatality rate
      • Various Immune responses
      • Different vaccines
      • Trials and results
      • Vaccination and next steps
    • Is it wise to vaccinate?
    • Test, trace & isolate.
    • Different tests
    • Avoid contimination
    • No herd immunity
    • A safe and efficient COVID-19 Vaccine
    • The disease and long-term effects
    • Lost at familiar property
    • Corona Dashboard. 2.0
    • How to fight COVID-19
  • ORTEC
    • P4O2 COVID-19
    • Data science leukemia
    • ​Data to improve patient care
    • Clinical decision support
    • U-Prevent
  • Federa
    • Associations of the Federa
  • Hartblik - blogs
  • Home
  • Nederlands
  • Resume
    • Science
    • Recent Research
    • Cancer immunotherapy
  • COVID-19
    • Herd Immunity Re-Revisted
      • 1 About herd immunity (HIRR).
      • 2 Three failed attempts.(HIRR)
      • 3. Calculate the costs (HIRR).
      • 4. Incomplete immunity (HIRR).
      • 5. What could possibly go wrong? (HIRR)
      • 6. How should we act? (HIRR)
      • 7. In brief. (HIRR)
    • Simple & complex
    • Epidemic Control
      • Epidemic Control Addendum
    • Summary Two years of COVID-19
    • Two years of COVID-19
      • I. Healthcare threat
      • II. Deceptive virus
      • III. Morbid tales
      • IV. Antivirus immunity
      • V. Stop the outbreak
      • VI. Dark and light reflections
      • VII. Looking forward
    • Humanitarian
    • Questions
      • Disease
      • Vaccines
      • Immunity
      • Epidemics
      • Mutation
      • Politics
    • Virus ethics
      • Transparency
      • Strife
      • Beyond Mortality
      • Special immunity
      • Vaccination
      • Prevent contamination
    • Non-sterilizing immunity
    • Immune responses and vaccines
      • Calculation of infection fatality rate
      • Various Immune responses
      • Different vaccines
      • Trials and results
      • Vaccination and next steps
    • Is it wise to vaccinate?
    • Test, trace & isolate.
    • Different tests
    • Avoid contimination
    • No herd immunity
    • A safe and efficient COVID-19 Vaccine
    • The disease and long-term effects
    • Lost at familiar property
    • Corona Dashboard. 2.0
    • How to fight COVID-19
  • ORTEC
    • P4O2 COVID-19
    • Data science leukemia
    • ​Data to improve patient care
    • Clinical decision support
    • U-Prevent
  • Federa
    • Associations of the Federa
  • Hartblik - blogs

Federa.
1959-2020
Dutch Society of Medical Scientific Associations.

Picture

Nederlandse pagina met links naar verenigingen
Associations that were members of the Federa
Sorted on discipline. * Left before 2012.The Dutch page has links to most associations
  • Dutch Association for Allergy
  • Dutch Association for Anaesthesiology*
  • Dutch Anatomists Association
  • Dutch Association for Angiology*
  • Dutch Association for Audiology*
  • Dutch Association for Biochemistry and Molecular Biology
  • Dutch Association for Biomaterials and Tissue Engineering*
  • Association for Biophysics*
  • Dutch Society for Cardiology
  • Dutch Society for Cell Biology
  • Dutch Association for Clinical Chemistry and Laboratory Medicine
  • Dutch Society for Clinical Cytology
  • Dutch Association for Clinical Geriatrics
  • Dutch Association for Clinical Pharmacology and Biopharmacy
  • Dutch Association for Community Genetics*
  • Dutch Association for Dance and Music Medicine
  • Dutch Society for Dermatology and Venereology
  • Dutch Association for Developmental Biology
  • Dutch Association for Diabetes Research*
  • Dutch Diving Medicine Association*
  • Dutch Society for Endocrinology*
  • Association for Epidemiology*
  • Dutch Association for Experimental and Clinical Neurochemistry*
  • Dutch Society for Experimental Dermatology
  • Netherlands Academy of Nutritional Sciences*
  • Dutch Association for Gastroenterology
  • Dutch Association for Gene Therapy
  • Dutch College of General Practitioners
  • Dutch Genetic Association*
  • Dutch Gerontology Association - Biological section*
  • Dutch Association for the Study of Glycoconjugates*
  • Dutch Hematology Society*
  • Dutch Association for Hepatology*
  • Dutch Association of Hospital Pharmacists*
  • Dutch Society for Human Genetics*
  • Dutch Association for Movement Sciences
  • Dutch Immunology Society
  • Association for Infectious Diseases
  • Association for Information Processing in Healthcare*
  • Interdisciplinary Society for Biological Psychiatry*
  • Dutch Internists Association*
  • Dutch Society for Laboratory Animal Science
  • Dutch Association of Physicians for Lung Diseases and Tuberculosis*
  • Dutch Society for Matrix Biology*
  • Dutch Association for Medical Microbiology
  • Dutch Association for Medical Oncology*
  • Association of Medical Scientific Researchers*
  • Dutch Association of Physicians for the Disabled*
  • Dutch Society for Nephrology
  • Dutch Neurology Society*
  • Dutch Society for Neuropathology
  • Dutch Society for Neuropsychology*
  • Dutch Association for Nuclear Medicine
  • Dutch Association for Obstetrics and Gynecology*
  • Dutch Society for Oncology
  •  Dutch Ophthalmology Company
  • Dutch Association for Biology of the Mouth*
  • Dutch Orthopedic Association*
  • Dutch Association for the Study of Pain*
  • Dutch Association for Parasitology*
  • Dutch Pathology Association*
  • Dutch General Medical Association
  • Dutch Pediatrics Association*
  • Dutch Association of Pharmaceutical Medicine*
  • Pharmacochemistry of the Royal Dutch Chemical Society, Section*
  • Dutch Pharmacology Association*
  • Dutch Society for Philosophy of Medicine
  • Dutch Association for Physiology*
  • Dutch Association for Phytotherapy*
  • Dutch Association for Psychiatry and Neurology
  • Dutch Association for Psychosomatic Research*
  • Dutch Society for Radiodiagnostics*
  • Dutch Society for Radiobiology*
  • Dutch Association of Physicians for Rehabilitation and Physical Medicine*
  • Dutch Association for Research Nurses*
  • Dutch Society for Rheumatology*
  • Dutch Association for the Study of Sexually Transmitted Diseases
  • Association for Sports Medicine*
  • Dutch Statistics Association - Medical Biological Section
  • Dutch Society for Surgery
  • Dutch Society for Thoracic Surgery*
  • Dutch Ear, Nose and Throat Association
  • Dutch Association for Thrombosis and Hemostasis*
  • Dutch Society for Toxicology*
  • Dutch Society for Urology*
  • Dutch Zoological Society - Section Comparative and General Physiology
Powered by Create your own unique website with customizable templates.
  • Home
  • Nederlands
  • Resume
    • Science
    • Recent Research
    • Cancer immunotherapy
  • COVID-19
    • Herd Immunity Re-Revisted
      • 1 About herd immunity (HIRR).
      • 2 Three failed attempts.(HIRR)
      • 3. Calculate the costs (HIRR).
      • 4. Incomplete immunity (HIRR).
      • 5. What could possibly go wrong? (HIRR)
      • 6. How should we act? (HIRR)
      • 7. In brief. (HIRR)
    • Simple & complex
    • Epidemic Control
      • Epidemic Control Addendum
    • Summary Two years of COVID-19
    • Two years of COVID-19
      • I. Healthcare threat
      • II. Deceptive virus
      • III. Morbid tales
      • IV. Antivirus immunity
      • V. Stop the outbreak
      • VI. Dark and light reflections
      • VII. Looking forward
    • Humanitarian
    • Questions
      • Disease
      • Vaccines
      • Immunity
      • Epidemics
      • Mutation
      • Politics
    • Virus ethics
      • Transparency
      • Strife
      • Beyond Mortality
      • Special immunity
      • Vaccination
      • Prevent contamination
    • Non-sterilizing immunity
    • Immune responses and vaccines
      • Calculation of infection fatality rate
      • Various Immune responses
      • Different vaccines
      • Trials and results
      • Vaccination and next steps
    • Is it wise to vaccinate?
    • Test, trace & isolate.
    • Different tests
    • Avoid contimination
    • No herd immunity
    • A safe and efficient COVID-19 Vaccine
    • The disease and long-term effects
    • Lost at familiar property
    • Corona Dashboard. 2.0
    • How to fight COVID-19
  • ORTEC
    • P4O2 COVID-19
    • Data science leukemia
    • ​Data to improve patient care
    • Clinical decision support
    • U-Prevent
  • Federa
    • Associations of the Federa
  • Hartblik - blogs